Tyrosine Kinase Inhibitors and Pregnancy

The management of patients with chronic myeloid leukemia (CML) during pregnancy has become recently a matter of continuous debate. The introduction of the Tyrosine Kinase Inhibitors (TKIs) in clinical practice has dramatically changed the prognosis of CML patients; in fact, patients diagnosed in chr...

Descripción completa

Detalles Bibliográficos
Autores principales: Abruzzese, Elisabetta, Trawinska, Malgorzata Monika, Perrotti, Alessio Pio, De Fabritiis, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010610/
https://www.ncbi.nlm.nih.gov/pubmed/24804001
http://dx.doi.org/10.4084/MJHID.2014.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010610/
https://www.ncbi.nlm.nih.gov/pubmed/24804001
http://dx.doi.org/10.4084/MJHID.2014.028

Ejemplares similares